ENTRY       D12228                      Drug
NAME        Bepranemab (USAN/INN)
FORMULA     C6482H10008N1702O2045S44
EXACT_MASS  145819.9164
MOL_WEIGHT  145909.8573
SEQUENCE    (Heavy chain)
            EVQLQESGPG LVKPSETLSL TCTVSGFSLT SNDIAWIRQP PGKGLEWMGT IWTDGSTNYN
            TAVQSRVTIS VDTSKNQFSL KLSSVTAADT AVYYCARHRL YYGAFDYWGQ GTMVTVSSAS
            TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFLGGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV
            VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP PSQEEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV DKSRWQEGNV
            FSCSVMHEAL HNHYTQKSLS LSLGK
            (Light chain)
            DIVMTQTPLS LSVTPGQPAS ISCRSSQSLE YSDGYTYLEW YLQKPGQSPQ LLIYEVSNRF
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCFQATHNP YTFGQGTKLE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H95, H132-L219, H145-H201, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'95, H'132-L'219, H'201-H'145, H'259-H'319, H'365-H'423, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Anti-tau protein antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of progressive supranuclear palsy and Alzheimer's disease
TARGET      MAPT (TAU) [HSA:4137] [KO:K04380]
  PATHWAY   hsa04010(4137)  MAPK signaling pathway
            hsa05010(4137)  Alzheimer disease
            hsa05022(4137)  Pathways of neurodegeneration - multiple diseases
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                MAPT (TAU)
                 D12228  Bepranemab (USAN/INN)
DBLINKS     CAS: 2244960-75-4
///
